Variant IRAK-1 haplotype is associated with increased nuclear factor-κB activation and worse outcomes in sepsis

被引:108
作者
Arcaroli, John
Silva, Eliezer
Maloney, James P.
He, Qianbin
Svetkauskaite, Daiva
Murphy, James R.
Abraham, Edward
机构
[1] Univ Sao Paulo, Intens Care Unit, Albert Einstein Hosp, Sao Paulo, Brazil
[2] Univ Sao Paulo, Div Appl Physiol, Inst Heart, Sao Paulo, Brazil
[3] Univ Colorado, Hlth Sci Ctr, Div Pulm Sci & Crit Care Med, Denver, CO USA
[4] Natl Jewish Med & Res Ctr, Dept Biostat, Denver, CO USA
关键词
acute lung injury; haplotype; inflammation; neutrophil; NF-kappa B; single nucleotide polymorphism;
D O I
10.1164/rccm.200603-341OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: The IL-1 receptor-associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-kappa B, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators. There are two haplo-types for the IRAK-1 gene in Caucasians, with the variant haplotype consisting of five intron single-nucleotide polymorphisms (SNPs) and three exon SNPs. Objectives: To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-kappa B and affecting outcomes from sepsis. Measurements and Main Results: One hundred fifty-five Caucasian patients with sepsis were included. Twenty-one (14%) were homozygous for the IRAK-1 variant haplotype as determined by a SNP in which T is replaced with C at nucleotide 1,595 within exon 12 of the IRAK-1 gene. The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-kappa B in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p = 0.0009). There was an increased incidence of shock (p = 0.047) (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1-7.7), greater requirement for more prolonged mechanical ventilator support (p = 0.04) (OR, 2.7; 95% CI, 1.05-6.9), and higher 60-d mortality (p = 0.05) (OR, 2.7; 95% CI, 1.0-6.8) in patients with the IRAK-1 variant haplotype compared with wild type. Conclusions: These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-kappa B, more severe organ dysfunction, and higher mortality.
引用
收藏
页码:1335 / 1341
页数:7
相关论文
共 58 条
[1]   Activation of extracellular signal-regulated kinases, NF-κB, and cyclic adenosine 5′-monophosphate response element-binding protein in lung neutrophils occurs by differing mechanisms after hemorrhage or endotoxemia [J].
Abraham, E ;
Arcaroli, J ;
Shenkar, R .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :522-530
[2]   NF-κB activation [J].
Abraham, E .
CRITICAL CARE MEDICINE, 2000, 28 (04) :N100-N104
[3]   Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury [J].
Abraham, E ;
Carmody, A ;
Shenkar, R ;
Arcaroli, J .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (06) :L1137-L1145
[4]  
*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801
[5]   Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].
Angus, DC ;
Linde-Zwirble, WT ;
Lidicker, J ;
Clermont, G ;
Carcillo, J ;
Pinsky, MR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1303-1310
[6]   Predictive value of nuclear factor κB activity and plasma cytokine levels in patients with sepsis [J].
Arnalich, F ;
Garcia-Palomero, E ;
López, J ;
Jiménez, M ;
Madero, R ;
Renart, J ;
Vazquez, JJ ;
Montiel, C .
INFECTION AND IMMUNITY, 2000, 68 (04) :1942-1945
[7]   Critical role for lysines 21 and 22 in signal-induced, ubiquitin-mediated proteolysis of I kappa B-alpha [J].
Baldi, L ;
Brown, K ;
Franzoso, G ;
Siebenlist, U .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (01) :376-379
[8]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[9]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[10]  
Blackwell TS, 1996, J IMMUNOL, V157, P1630